Sukhtian Faisal Ghiath (CIK 1716033) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-29). Recent activity: Buy OTLK (95,398 shares), Buy OTLK (122,174 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 95,398 | $99,996 |
| 2026-05-27 | Outlook Therapeutics, Inc. (OTLK) | Director | Buy | 122,174 | $50,006 |
Source: SEC Form 4 filings · as of 2026-07-29